Neurology Alert (Vol. 35, No. 7) - March 1, 2016

Read the Disclosure Information Below, then click “Continue” to begin testing.

Release date: March 2016

Valid through: March 2019

Target Audience

This activity is intended for the neurologist.

Subjects

  • Sonographic Diagnosis of Inclusion Body Myositis
  • Intraoperative Neurophysiologic Monitoring: Does it Change the Outcome from Spinal Surgery?
  • Does Rivastigmine Prevent Falls in Parkinson’s Disease?
  • Tranexamic Acid-associated Seizures: Features, Mechanisms, and Treatment
  • Overdiagnosis of Idiopathic Intracranial Hypertension
  • Symptomatic Carotid Artery Stenosis Requires Urgent Revascularization
  • Intracerebral Hemorrhages Associated with Non-vitamin K Oral Anticoagulants Appear to Be Smaller than Those Associated with Warfarin
  • Isolated Dizziness and Vertigo Are Rarely Caused by Stroke

Objectives

  • Discuss current scientific data regarding the diagnosis and treatment of neurological disease
  • Discuss the pathogenesis and treatment of pain
  • Describe the basic science of brain function
  • Discuss new information regarding new drugs for commonly diagnosed neurological conditions

Credit Available

Physicians

  • Maximum of 2.25 AMA PRA Category 1 Credits

Sponsor

This activity is sponsored by AHC Media.

Accreditation Statement

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Physicians

AHC Media designates this enduring material for a maximum of 2.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Listing

Authors

Michael Rubin, MD, Professor of Clinical Neurology, Weill Cornell Medical College

Steven Karceski, MD, Assistant Professor of Neurology, Weill Cornell Medical College

Claire Henchcliffe, MD, Associate Professor of Neurology and Neuroscience, Weill Cornell Medical College

Kimberly Pargeon, MD, Assistant Professor of Clinical Neurology, Weill Cornell Medical College

Louise M. Klebanoff, MD, Assistant Professor of Clinical Neurology, Weill Cornell Medical College

Matthew E. Fink, MD, Louis and Gertrude Feil Professor in Clinical Neurology, Chairman, Department of Neurology, Weill Cornell Medical College, Neurologist-in-Chief, New York Presbyterian Hospital

Editors

Medical Editor: Matthew E. Fink, MD, Louis and Gertrude Feil Professor in Clinical Neurology, Chairman, Department of Neurology, Weill Cornell Medical College, Neurologist-in-Chief, New York Presbyterian Hospital

AHC Media Executive Editor: Leslie G. Coplin

Managing Editor: Jonathan Springston

Financial Disclosure

Author Steven Karceski, MD reports he is on the speakers bureau for LivaNova. Author Claire Henchcliffe, MD, reports she is on the speakers bureau and advisory boards for Teva, IMPAX, and ACADIA, and receives grant/research support from Biogen and Kaneka. Editor Matthew E. Fink, MD reports he is a retained consultant for Procter & Gamble and Pfizer.  

Authors Michael Rubin, MD; Kimberly Pargeon, MD; and Louise M. Klebanoff, MD report no financial relationships relevant to this field of study.

Neurology Alert's editor in chief, Matthew E. Fink, MD reports he is a retained consultant for Procter & Gamble and Pfizer. Peer reviewer M. Flint Beal, MD; executive editor Leslie Coplin; and associate managing editor Jonathan Springston report no financial relationships relevant to this field of study.

Copyright 2016, AHC Media. All rights reserved.